Are patent medicine vendors effective agents in malaria control?
There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery.
Information, given to patients about side-effects by Lithuanian GPs, is not in accordance with the principle of respect for patients' autonomy and requirements of Lithuanian legislation.